XWPharma
PrivateLast Round
Series C
Sep 17, 2020
Total Funding Raised
$63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
XWPharma is a biotechnology company that develops innovative therapeutics to address sleep, neuropsychological, and other neglected central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XWPharma Comparables
Compare XWPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CuraSen Therapeutics, Inc. | 77% | |
| Avadel Pharmaceuticals PLC | 75% | |
| Sage Therapeutics | 74% | |
XWPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2020 | ||||
| Series B | Sep 20, 2017 | ||||
| Series A | Sep 1, 2014 |
XWPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kleiner Perkins China | Series A |
| WI Harper Group | Series C, Series B |
| Orient Hontai Capital | Series C |
| KTB Ventures | Series B, Series C |
| SANY Group | Series C |
| Daol Investment | Series B, Series C |
| Kleiner Perkins | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Grew 37% QoQ, from 19 to 26 employees.
- Apr 18, 2026
Grew 35% QoQ, from 17 to 23 employees.
XWPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XWPharma's valuation, stock price, and market status.